ArticleVirulence2025

Ponatinib and other clinically approved inhibitors of Src and Rho-A kinases abrogate dengue virus serotype 2- induced endothelial permeability.

Srishti Rajkumar Mishra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.